Senate Health Committee Approves FDA Nominee

Alexander calls Dr. Califf “a qualified nominee who will help guide an agency that affects nearly every single American and regulates over $4 trillion annually”

WASHINGTON, D.C., Jan. 12 – Chairman Lamar Alexander (R-Tenn.) today made the following statement on the Senate health committee’s approval of Dr. Robert Califf to head the Food and Drug Administration (FDA):

“The FDA affects the lives of nearly every single American and regulates about a quarter of all consumer spending in the United States—over $4 trillion annually. Americans need competent leadership to head this significant agency and to help bring safe drugs and devices to market faster and protect our nation’s food supply. The Senate should consider Dr. Califf’s nomination quickly to fill this important role.”

The Senate health committee held a hearing on Nov. 17 to consider Dr. Califf’s nomination. Click here for Chairman Alexander’s remarks at that hearing.


For access to this release and Chairman Alexander’s other statements, click here.

Press Contact


Margaret Atkinson / Jim Jeffries: 202-224-0387